Atlas Trials

A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer

Clinical trial NCT00337649 · COMPLETED

Trial details

NCT number
NCT00337649
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2004-05-01
Primary completion
2007-07-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.